<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04950634</url>
  </required_header>
  <id_info>
    <org_study_id>189/17</org_study_id>
    <nct_id>NCT04950634</nct_id>
  </id_info>
  <brief_title>Sexual Dimorphism in Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes</brief_title>
  <official_title>Sexual Dimorphism in the Prevalence and Progression of Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sex might interact with cardioautonomic neuropathy (CAN) in the development of macrovascular&#xD;
      disease in patients with type 1 diabetes (T1D). The regulation of the autonomic system shows&#xD;
      sexual dimorphism, and may contribute to the cardiovascular risk overload in women with T1D.&#xD;
&#xD;
      The aims of this project are:&#xD;
&#xD;
      A.1) Determining the prevalence of CAN and subclinical atherosclerosis in a large cohort of&#xD;
      consecutive patients with T1D as a function of sex (cross-sectional study).&#xD;
&#xD;
      A.2.) Addressing the progression of CAN and subclinical atherosclerosis in patients with T1D&#xD;
      as a function of sex (longitudinal prospective study).&#xD;
&#xD;
      A.3.) Investigating the influence of sex steroids and circulating biomarkers in the&#xD;
      development and progression of CAN and subclinical atherosclerosis.&#xD;
&#xD;
      Research designs:&#xD;
&#xD;
      A cross-sectional design/prevalence screening study determining the prevalence of CAN as a&#xD;
      function of sex in 320 consecutive individuals with DM1.&#xD;
&#xD;
      A longitudinal prospective study: the cohort of prevalence screening study will be&#xD;
      prospectively followed, and the assessment of cardiovascular autonomic function and&#xD;
      subclinical atherosclerosis will be repeated over time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To address sexual dimorphism in the prevalence of CAN in patients with T1D.</measure>
    <time_frame>Two years</time_frame>
    <description>Blood pressure (mmHg) to active standing and Ewing and Clarke tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To address sexual dimorphism in the prevalence of CAN in patients with T1D.</measure>
    <time_frame>Two years</time_frame>
    <description>Heart rate responses (bpm) to active standing and Ewing and Clarke tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To address sexual dimorphism in subclinical atherosclerosis in patients with T1D.</measure>
    <time_frame>Two years</time_frame>
    <description>Mean carotid intima-media thickness (mm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the role of sex on the progression of cardiovascular dysautonomy in patients with T1D.</measure>
    <time_frame>Four years</time_frame>
    <description>Blood pressure (mmHg) to active standing and Ewing and Clarke tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the role of sex on the progression of cardiovascular dysautonomy in patients with T1D.</measure>
    <time_frame>Four years</time_frame>
    <description>Heart rate responses (bpm) to active standing and Ewing and Clarke tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the role of sex on the progression of subclinical atherosclerosis in patients with T1D.</measure>
    <time_frame>Four years</time_frame>
    <description>Mean carotid intima-media thickness (mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To identify the influence of sex steroids on the evolution of cardiac autonomic dysfunction.</measure>
    <time_frame>Four years</time_frame>
    <description>Heart rate responses (bpm) to active standing and Ewing and Clarke tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the influence of sex steroids on the evolution of cardiac autonomic dysfunction.</measure>
    <time_frame>Four years</time_frame>
    <description>Blood pressure (mmHg) to active standing and Ewing and Clarke tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the influence of sex steroids on the evolution of subclinical atherosclerosis</measure>
    <time_frame>Four years</time_frame>
    <description>Mean carotid intima-media thickness (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify novel circulating markers of CAN</measure>
    <time_frame>Four years</time_frame>
    <description>Heart rate responses (bpm) to active standing and Ewing and Clarke tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify novel circulating markers of CAN</measure>
    <time_frame>Four years</time_frame>
    <description>Blood pressure (mmHg) to active standing and Ewing and Clarke tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify novel circulating markers of subclinical atherosclerosis</measure>
    <time_frame>Four years</time_frame>
    <description>Mean carotid intima-media thickness (mm)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">320</enrollment>
  <condition>type1diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants are selected from a consecutive cohort of individuals with T1D, who are&#xD;
        regularly attending the outpatient clinic of the Diabetes Unit from Hospital Universitario&#xD;
        Ramón y Cajal of Madrid.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Diagnosis of type 1 diabetes mellitus, as defined by ADA criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Renal transplantation or renal replacement therapy;&#xD;
&#xD;
          -  prior diagnosis of macrovascular disease (CHD, cerebrovascular disease, carotid&#xD;
             disease, PAD, or atherosclerotic aortic aneurism);&#xD;
&#xD;
          -  ongoing pregnancy;&#xD;
&#xD;
          -  diagnosis of types of diabetes mellitus other than type 1;&#xD;
&#xD;
          -  diagnosis of types of neuropathy other than diabetic neuropathy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lía Nattero Chávez, MD PhD</last_name>
    <phone>+34913369029</phone>
    <email>marialia.nattero@salud.madrid.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manuel Luque-Ramírez, MD PhD</last_name>
    <phone>+34913369029</phone>
    <email>manuel.luque@salud.madrid.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lía Nattero Chávez</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lía Nattero Chávez, MD PhD</last_name>
      <phone>+34913369029</phone>
      <email>marialia.nattero@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Manuel Luque-Ramírez, MD PhD</last_name>
      <phone>+34913369029</phone>
      <email>manuel.luque@salud.madrid.org</email>
    </contact_backup>
    <investigator>
      <last_name>Lía Nattero-Chávez, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 30, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardioautonomic neuropathy</keyword>
  <keyword>sexual dimorphism</keyword>
  <keyword>subclinical atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

